158 related articles for article (PubMed ID: 26096778)
1. Prenatal exposure to H2 blockers and to proton pump inhibitors and asthma development in offspring.
Yitshak-Sade M; Gorodischer R; Aviram M; Novack L
J Clin Pharmacol; 2016 Jan; 56(1):116-23. PubMed ID: 26096778
[TBL] [Abstract][Full Text] [Related]
2. Exposure to acid-suppressing drugs during pregnancy and the risk of asthma in childhood: an observational cohort study.
Cea Soriano L; Hernández-Díaz S; Johansson S; Nagy P; García-Rodríguez LA
Aliment Pharmacol Ther; 2016 Feb; 43(3):427-37. PubMed ID: 26612701
[TBL] [Abstract][Full Text] [Related]
3. Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study.
Andersen AB; Erichsen R; Farkas DK; Mehnert F; Ehrenstein V; Sørensen HT
Aliment Pharmacol Ther; 2012 May; 35(10):1190-8. PubMed ID: 22443179
[TBL] [Abstract][Full Text] [Related]
4. Acid-suppressive medications during pregnancy and risk of asthma and allergy in the offspring: protocol for a systematic review.
Devine RE; Sheikh A; Nwaru BI
NPJ Prim Care Respir Med; 2016 Mar; 26():16001. PubMed ID: 26934831
[No Abstract] [Full Text] [Related]
5. First evidence of a possible association between gastric acid suppression during pregnancy and childhood asthma: a population-based register study.
Dehlink E; Yen E; Leichtner AM; Hait EJ; Fiebiger E
Clin Exp Allergy; 2009 Feb; 39(2):246-53. PubMed ID: 19134022
[TBL] [Abstract][Full Text] [Related]
6. Prenatal and Infant Exposure to Acid-Suppressive Medications and Risk of Allergic Diseases in Children.
Noh Y; Jeong HE; Choi A; Choi EY; Pasternak B; Nordeng H; Bliddal M; Man KKC; Wong ICK; Yon DK; Shin JY
JAMA Pediatr; 2023 Mar; 177(3):267-277. PubMed ID: 36622684
[TBL] [Abstract][Full Text] [Related]
7. Prenatal exposure to acid-suppressive drugs and the risk of allergic diseases in the offspring: a cohort study.
Mulder B; Schuiling-Veninga CC; Bos HJ; De Vries TW; Jick SS; Hak E
Clin Exp Allergy; 2014 Feb; 44(2):261-9. PubMed ID: 24164287
[TBL] [Abstract][Full Text] [Related]
8. Prenatal exposure to acid-suppressant medications and the risk of recurrent wheeze at 3 years of age in children with a history of severe bronchiolitis.
Robinson LB; Chen Arroyo AJ; Dantas MAS; Espinola JA; Sullivan AF; Camargo CA
J Allergy Clin Immunol Pract; 2019; 7(7):2422-2424.e4. PubMed ID: 30878709
[No Abstract] [Full Text] [Related]
9. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.
Cohen S; Bueno de Mesquita M; Mimouni FB
Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
Lazzaroni M; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term acid suppression therapy with proton pump inhibitors or H
Damodharan S; Raj GM; Sakthibalan M; Dakshinamoorthy K; Muraliswaran P
Ir J Med Sci; 2021 Aug; 190(3):1213-1217. PubMed ID: 33085017
[TBL] [Abstract][Full Text] [Related]
12. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
Lucas LM; Gerrity MS; Anderson T
Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
[TBL] [Abstract][Full Text] [Related]
13. The safety of fetal exposure to proton-pump inhibitors during pregnancy.
Matok I; Levy A; Wiznitzer A; Uziel E; Koren G; Gorodischer R
Dig Dis Sci; 2012 Mar; 57(3):699-705. PubMed ID: 22038541
[TBL] [Abstract][Full Text] [Related]
14. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
Sakurada T; Kawashima J; Ariyama S; Kani K; Takabayashi H; Ohno S; Kato S; Yakabi K
Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833
[TBL] [Abstract][Full Text] [Related]
15. Acid-suppressive medication and incidence of chronic childhood immune-mediated diseases: A scoping review.
Madej J; Atanassova T; McGuire S; Cohen B; Weidner M; Zhang Y; Horton DB
Pediatr Allergy Immunol; 2023 Nov; 34(11):e14042. PubMed ID: 38010007
[TBL] [Abstract][Full Text] [Related]
16. Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database.
Costarino AT; Dai D; Feng R; Feudtner C; Guevara JP
Pediatr Crit Care Med; 2015 Sep; 16(7):605-12. PubMed ID: 25901549
[TBL] [Abstract][Full Text] [Related]
17. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
[TBL] [Abstract][Full Text] [Related]
19. Comparison tables: H2-receptor antagonists and PPIs.
Med Lett Drugs Ther; 2022 Apr; 64(1647):e56-e57. PubMed ID: 35348553
[No Abstract] [Full Text] [Related]
20. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
Tofil NM; Benner KW; Fuller MP; Winkler MK
J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
